On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC11018358 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature